Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12617001013358
Ethics application status
Approved
Date submitted
3/07/2017
Date registered
14/07/2017
Date last updated
15/04/2024
Date data sharing statement initially provided
15/04/2024
Date results provided
15/04/2024
Type of registration
Prospectively registered

Titles & IDs
Public title
TARGET study: Exercise for people with knee osteoarthritis and obesity
Scientific title
Target study: Comparison of weight bearing functional exercise and non-weight bearing quadriceps strengthening exercise on pain and function for people with knee osteoarthritis and obesity.
Secondary ID [1] 289914 0
None
Universal Trial Number (UTN)
U1111-1186-3614
Trial acronym
TARGET
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Osteoarthritis 299882 0
Obesity 299883 0
Condition category
Condition code
Musculoskeletal 299786 299786 0 0
Osteoarthritis

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Description of intervention(s) / exposure: This randomised controlled trial will compare two exercise interventions.

Both interventions will comprise of 5 individual, in clinic physiotherapist-supervised exercise sessions (30-40-minute) and a 4 x weekly home exercise program over the same 12 week period.

In clinic physiotherapy sessions will occur at weeks 1, 2, 4, 7 and 10.

Home exercise sessions will be approximately 20-30 minutes in duration and occur at the participants chosen time 4 times each week.

The two exercise interventions are;
i) weight bearing functional exercise which includes 5 weight bearing exercises with progressions performed using body weight resistance, elastic bands, foam mats and a small step; and,
ii) non-weight bearing quadriceps strengthening which includes 5 non-weight bearing exercises, with resistance provided by ankle weights or elastic bands.

The intensity and progressions of the exercise programs will be determined by the physiotherapist in discussion with the participant. Participants will be provided exercise equipment required.

Adherence to the exercise program will be captured via questionnaire at the 12 week time point. Adherence to the 5 clinic physiotherapy sessions will be recorded by the physiotherapists in their study case notes. Treatment fidelity will be scored by an assessment of the physiotherapist treatment notes, and fidelity will be maintained through regular tele-conferences between physiotherapists and the research team.
Intervention code [1] 295595 0
Rehabilitation
Comparator / control treatment
We are comparing the effects of the two exercise groups described under “intervention”.
Control group
Active

Outcomes
Primary outcome [1] 299253 0
Overall average pain in the past week on an 11-pont numeric rating scale
Timepoint [1] 299253 0
Baseline and 12 weeks after baseline
Primary outcome [2] 301433 0
Physical function sub-scale of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
(scores will be extracted from the Knee Injury and Osteoarthritis Outcome Score (KOOS)questionnaire which contains the WOMAC questions.)
Timepoint [2] 301433 0
Baseline and 12 weeks after baseline
Secondary outcome [1] 326649 0
Average pain on walking in the past week on an 11-point numeric rating scale
Timepoint [1] 326649 0
Baseline and 12 weeks after baseline
Secondary outcome [2] 326650 0
Knee Injury and Osteoarthritis Outcome Score (KOOS)
This includes subscales
i) pain
ii) other symptoms
iii) function in sport and recreation
iv) knee related quality of life
Timepoint [2] 326650 0
Baseline and 12 weeks after baseline
Secondary outcome [3] 326651 0
Health related quality of life - AQoL2
Timepoint [3] 326651 0
Baseline and 12 weeks after baseline
Secondary outcome [4] 335920 0
Functional test 1.
30 second chair sit to stand
Timepoint [4] 335920 0
Baseline and 12 weeks after baseline
Secondary outcome [5] 335921 0
Functional test 2.
40m fast paced walk
Timepoint [5] 335921 0
Baseline and 12 weeks after baseline
Secondary outcome [6] 335922 0
Functional test 3.
6-step stair climb
Timepoint [6] 335922 0
Baseline and 12 weeks after baseline
Secondary outcome [7] 335923 0
Functional test 4.
Timed single leg stance
Timepoint [7] 335923 0
Baseline and 12 weeks after baseline
Secondary outcome [8] 335924 0
Functional test 5.
Four square test
Timepoint [8] 335924 0
Baseline and 12 weeks after baseline
Secondary outcome [9] 335926 0
Global change overall rated on a 7 point numeric scale from much worse to much better.
Timepoint [9] 335926 0
12 weeks after baseline
Secondary outcome [10] 335927 0
Global change in pain rated on a 7 point numeric scale from much worse to much better.
Timepoint [10] 335927 0
12 weeks after baseline
Secondary outcome [11] 335928 0
Global change in function rated on a 7 point numeric scale from much worse to much better.
Timepoint [11] 335928 0
12 weeks after baseline
Secondary outcome [12] 336451 0
Quadriceps muscle strength Maximum voluntary isometric strength of the knee extensors will be assessed on an isokinetic dynamometer (HUMAC) with the knee at 90 degrees of knee flexion. Maximum torque reached over 3 repetitions of 3 seconds each is recorded and normalised to body weight (Nm/kg), with higher scores indicating greater strength.
Timepoint [12] 336451 0
Baseline and 12 weeks after baseline
Secondary outcome [13] 336452 0
Abductor muscle strength
Maximum voluntary isometric strength of the hip abductors will be assessed using a handheld dynamometer (Lafayette Manual Muscle Test System) with the hip in neutral abduction. Average force from 2 repetitions of 3 seconds each is recorded, converted to torque and normalised to body weight (Nm/kg), with higher scores indicating greater strength.
Timepoint [13] 336452 0
Baseline and 12 weeks after baseline

Eligibility
Key inclusion criteria
I. aged 50 years and above;
II. report knee pain on most days of the past month;
III. suffered knee pain for 3 months or more;
IV. report a minimum average overall pain score of 4 on an 11-point numeric rating scale over the previous week;
V. demonstrate tibiofemoral osteophytes on x-ray;
VI. obesity (BMI of 30 kg/m2 and over);
VII. have a mobile phone that has text messaging functionality and be happy to receive text message reminders if required during the study.
Minimum age
50 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
I. Lateral joint space narrowing greater than or equal to medial joint space narrowing on x-ray;
II. knee surgery/joint injection in past 6 months or planned surgery in the next 9 months;
III. current or past (4 weeks) oral corticosteroids;
IV. systemic arthritic conditions;
V. past knee fracture or malignancy;
VI. past hip/knee joint replacement/tibial osteotomy;
VII. other condition currently affecting lower limb function;
VIII. participation in knee strengthening or neuromuscular exercise in past 6 months or planning to start exercise in next 9 months;
IX. unable to walk unaided;
X. unable to commit to study requirements (Unable to attend study appointments or complete study outcomes)

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
The person who will determine if a potential participant is eligible for inclusion in the trial will be unaware, when this decision is made, to which group the participant will be allocated. Another researcher will access the randomisation schedule via computer, concealed in a password protected database.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Randomization will occur according to a 1: 1 allocation and be stratified by physiotherapist and physiotherapy clinic. The randomisation schedule will be computer generated, using random permuted blocks of varying sizes. To conceal allocation, the randomisation schedule will be accessed via a password-protected, computer program by a researcher not involved in participant recruitment scheduling or assessment.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Sample Size calculation: For an effect size of 0.5, power 80% and two-sided significance level 0.05, with a correlation between pre- and post-measurements of 0.45 for pain, 51 participants per arm will be required (using ANCOVA for analysis including baseline pain measurement as a covariate). To account for 20% loss to follow up, sample size will be increased to 64 per arm, for a total of 128. This gives power of 83% to detect an effect size of 0.5 for function with a correlation between pre- and post-measurements of 0.49 and a two-sided significance level of 0.05.
128 participants will be recruited and randomised.

Statistical Analysis Plan: Analyses comparing the two treatment groups will be performed by the statistician in a blinded fashion using all available data from all participants randomised to an exercise group. Demographic and baseline characteristics of participants will be summarised as appropriate (means and standard deviations for continuous variables that appear to be approximately normally distributed, medians and interquartile ranges for other continuous variables, counts and percentages for categorical variables) and will be inspected to assess baseline comparability of treatment groups. For continuous outcomes, differences in change will be compared between groups using linear regression models adjusted for baseline levels of these outcomes, including random effects for treating physiotherapist to account for clustering by physiotherapist. Model assumptions will be assessed using standard diagnostic plots. For binary outcomes, differences between groups will be compared using relative risks, calculated from logistic regression models with random effects for treating physiotherapist. Should the amount of missing data for an outcome be such that imputation is required, multiple imputation will be conducted and the method reported.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
20/07/2017
Actual
18/09/2017
Date of last participant enrolment
Anticipated
12/07/2019
Actual
10/05/2019
Date of last data collection
Anticipated
12/10/2019
Actual
13/08/2019
Sample size
Target
128
Accrual to date
Final
128
Recruitment in Australia
Recruitment state(s)
VIC

Funding & Sponsors
Funding source category [1] 294280 0
Government body
Name [1] 294280 0
National Health and Medical Research Council (NHMRC)
Country [1] 294280 0
Australia
Primary sponsor type
University
Name
The University of Melbourne
Address
1-100 Grattan Street, Melbourne, Victoria, 3010
Country
Australia
Secondary sponsor category [1] 293114 0
None
Name [1] 293114 0
Address [1] 293114 0
Country [1] 293114 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 295712 0
University of Melbourne Human Research Ethics Committee (HREC), reference number 1544919
Ethics committee address [1] 295712 0
Ethics committee country [1] 295712 0
Australia
Date submitted for ethics approval [1] 295712 0
26/06/2015
Approval date [1] 295712 0
10/03/2017
Ethics approval number [1] 295712 0
1544919

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 68198 0
Prof Kim L Bennell
Address 68198 0
L7 161 Barry Street, The University of Melbourne, Victoria, Australia, 3010
Country 68198 0
Australia
Phone 68198 0
+61 3 8344 4135
Fax 68198 0
Email 68198 0
[email protected]
Contact person for public queries
Name 68199 0
Sarah Schwartz
Address 68199 0
L7 161 Barry Street, The University of Melbourne, Victoria, Australia, 3010
Country 68199 0
Australia
Phone 68199 0
+61 3 8344 8455
Fax 68199 0
Email 68199 0
[email protected]
Contact person for scientific queries
Name 68200 0
Kim L Bennell
Address 68200 0
L7 161 Barry Street, The University of Melbourne, Victoria, Australia,3010
Country 68200 0
Australia
Phone 68200 0
+61 3 8344 4135
Fax 68200 0
Email 68200 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Yes
What data in particular will be shared?
All data presented in the results paper (Osteoarthritis Cartilage. 2020 Jun;28(6):755-765.) available in XLSX format.
When will data be available (start and end dates)?
19-03-2020 to 19-03-2035 (a period of 15 years from publication)
Available to whom?
Data will be made available as required for specific, approved analyses by researchers. Data will be provided from locked, cleaned, and de- identified study database. Requests will be reviewed by the Principal Investigator prior to approval.
Available for what types of analyses?
The investigators endorse the concept of data sharing to advance medical science. All requests for data sharing will be reviewed by the Principal Investigator to ensure no conflict with any planned sub analyses and to ensure that the data are shared in an ethical and protected manner.

Analyses aimed to improve treatment of knee osteoarthritis for non-commercial purposes are eligible.
How or where can data be obtained?
By emailing the Principal Investigator at [email protected]. Data will be made available after review and approval by the Principal Investigator. Before any analysis, a signed Confidentiality Agreement and/or Data Sharing Agreement is required.


What supporting documents are/will be available?

Doc. No.TypeCitationLinkEmailOther DetailsAttachment
22200Data dictionary    The Data Dictionary will be supplied with the de-i... [More Details]



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
SourceTitleYear of PublicationDOI
EmbaseComparison of weight bearing functional exercise and non-weight bearing quadriceps strengthening exercise on pain and function for people with knee osteoarthritis and obesity: Protocol for the TARGET randomised controlled trial.2019https://dx.doi.org/10.1186/s12891-019-2662-5
EmbaseWhat type of exercise is most effective for people with knee osteoarthritis and co-morbid obesity?: The TARGET randomized controlled trial.2020https://dx.doi.org/10.1016/j.joca.2020.02.838
N.B. These documents automatically identified may not have been verified by the study sponsor.